2,3-Dihydroquinazolin-4(1H)-one derivatives as potent aldose reductase inhibitors: a combined experimental and computational study
 
Yazarlar (4)
Doç. Dr. Feyzi Sinan TOKALI Kafkas Üniversitesi, Türkiye
Yeliz Demir Ardahan Üniversitesi, Türkiye
Nurgül Abul Atatürk Üniversitesi, Türkiye
Doç. Dr. Halil Şenol Bezm-İ Âlem Vakıf Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Bioorganic Chemistry (Q1)
Dergi ISSN 0045-2068 Dergi Bilgileri (2026)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 09-2026
Cilt / Sayı / Sayfa 180 / 1 / – DOI 10.1016/j.bioorg.2026.110081
Makale Linki https://doi.org/10.1016/j.bioorg.2026.110081
UAK Araştırma Alanları
Organik Kimya
Özet
Abstract A series of sixteen 2,3-dihydroquinazolin-4(1 H )-one derivatives was designed and synthesized to evaluate their potential as aldose reductase (ALR2) inhibitors for the management of diabetic complications. The synthesized compounds were structurally characterized by FT-IR, NMR, and HRMS analyses, and their inhibitory activities were assessed through in vitro enzyme assays. All compounds exhibited notable ALR2 inhibition, with K i values ranging from 0.052 to 1.272 μM. Among them, compound 9 demonstrated the highest potency ( K i  = 0.052 μM), showing approximately 21-fold stronger activity than the reference inhibitor epalrestat ( K i  = 1.124 μM). Structure-activity relationship analysis revealed that para-positioned electron-donating substituents and optimally positioned hydrogen-bond donor groups significantly enhance inhibitory activity, while ortho substitution adversely affects binding …
Anahtar Kelimeler
2,3-dihydroquinazolin-4(1H)-one | Aldose reductase | ALR2 | Inhibition | Molecular dynamics
Science Direct
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 1
Scopus 2
Google Scholar 3
2,3-Dihydroquinazolin-4(1H)-one derivatives as potent aldose reductase inhibitors: a combined experimental and computational study

Paylaş